Highlights of the Program
2 days business program:
Learn from real-world case studies by industry leaders.
SHOWCASING INNOVATION:
Discover the latest technology and techniques from across the industry.
leaders talk:
Hear from top-level experts about how to stay ahead in a fast-changing industry.
MULTIPLE STREAMS:
A business program that is multi-disciplinary, giving you a broad view of the industry.
SMART TECHNOLOGIES:
Explore the latest smart and AI-driven solutions, and see how they can be used in your business.
roundtable discussion:
Join talks with industry peers. Share ideas, make connections, and find new partners.
Program
Day 1 :
WEDNESDAY, APRIL 29, 2026
08:30 - 09:30
REGISTRATION AND MORNING REFRESHMENTS
09:30 - 09:40
OPENING ADDRESS
09:40 - 10:05
AI-DISCOVERED PEPTIDES: A NON-PHARMACEUTICAL BREAKTHROUGH FOR WEIGHT MANAGEMENT
10:05 - 10:10
Q&A SESSION ON AI-DISCOVERED PEPTIDES FOR WEIGHT MANAGEMENT
10:10 - 10:35
GLOBAL PREVENTION OF DIABETES
- Linking diabetes risk to intestinal alkaline phosphatase deficiency and endotoxin detoxification processes
- Reviewing mouse evidence that bovine IAP supplementation prevents hyperglycemia in diabetic models
- Outlining how therapeutic-grade BIAP could be evaluated as a scalable diabetes-prevention approach
10:35 - 10:40
Q&A SESSION ON DIABETES PREVENTION
10:40 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
Sponsored By MADRIGAL PHARMACEUTICALS
11:00 - 11:30
PANEL DISCUSSION ON THE SILENT EPIDEMIC OF METABOLIC SYNDROME
- Uncovering barriers to early detection and prioritizing underestimated modern drivers to scale effective metabolic syndrome interventions
- Clarifying pivotal causes, diagnosing diabetes vulnerability, and applying practical prevention steps to stop progression from metabolic syndrome
- Reframing lifestyle design and coaching to overcome the limits of medical advice and exercise for durable population-scale reversal
| CVS Healthspire Payor Solutions | Moderator
| Lembas
| Stapgen LLC
| The Erring Human
11:30 - 11:55
REDEFINING SURGICAL BOUNDARIES: AI IN COLORECTAL SURGERY FOR PATIENTS WITH METABOLIC CHALLENGES
- Advancing AI, 3D printing, and machine learning integration for colorectal surgery in obesity care
- Enhancing patient understanding and shared decision-making when metabolic risk shapes surgical options
- Modernizing training with simulation and AI-guided planning for complex colorectal procedures
- Safeguarding equitable AI adoption by addressing bias, transparency, and clinical accountability
11:55 - 12:00
Q&A SESSION ON AI IN COLORECTAL SURGERY FOR METABOLIC RISKS
12:00 - 13:30
NETWORKING LUNCH AND VISITING THE OBESITY MEDICINE EXHIBITION
13:30 - 13:55
FINANCING AND CORPORATE TRANSACTIONS ENVIRONMENT IN METABOLIC MEDICINE: CURRENT TRENDS AND OUTLOOK FOR THE FUTURE
- Assessing how 2025 financing headwinds slow early-stage metabolic R&D and academic spinout formation
- Tracing the shift from late-stage deals to earlier licensing and partnering by major pharma groups
- Anticipating global impacts as China and Asian biotechs challenge U.S. and European deal dominance
13:55 - 14:00
Q&A SESSION ON FINANCING TRENDS IN METABOLIC MEDICINE
14:00 - 14:25
THE MIND/BODY PROBLEM – METABOLIC SYNDROME AND COGNITIVE DECLINE
- Clarifying the strong links between metabolic dysfunction and cognitive impairments
- Underscoring complications due to the late detection of cognitive decline in patients
- Showcasing innovative early detection tools to slow or prevent brain changes
- Integrating mind–body approaches to address both metabolic and cognitive issues
14:25 - 14:30
Q&A SESSION ON LINKING METABOLISM AND BRAIN HEALTH
14:30 - 14:55
DIGITAL INNOVATION IN METABOLIC PSYCHIATRY
14:55 - 15:00
Q&A SESSION ON DIGITAL METABOLIC PSYCHIATRY IN PRACTICE
15:00 - 15:30
AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
15:30 - 15:55
THE MIND–METABOLISM LOOP
- Presenting chronic psychological stress as the most systematically undertreated upstream driver of metabolic dysfunction and neurodegeneration — and why current treatment models keep arriving too late
- Mapping the Mind–Metabolism Loop — HPA axis dysregulation, glucose instability, vascular damage, blood–brain barrier compromise — and the intervention points where the cycle can be broken
- Reframing methylation and detoxification pathway variants as stress-sensitive risk amplifiers — a precision medicine opportunity hiding in plain sight
- Introducing a Resolution–Regulation–Optimization framework that sequences intervention from root cause forward, with implications for therapeutic development, clinical trial design, and patient outcomes
15:55 - 16:00
Q&A SESSION ON THE MIND-METABOLISM LOOP IN METABOLIC DISEASES
16:00 - 16:25
ENABLING DEVICE SOLUTIONS FOR UNMET NEEDS IN BIOTHERAPIES
16:25 - 16:30
Q&A SESSION ON ENABLING DEVICE SOLUTIONS IN BIOTHERAPIES
16:30 - 16:55
WHY LONG-TERM WEIGHT LOSS FAILS: A METABOLIC FEEDBACK LOOP PERSPECTIVE BEYOND CALORIES
- Examining metabolic and adaptive feedback loops that drive weight regain despite initial loss
- Explaining why calorie-focused and compliance-led models ignore hormonal and behavioral dynamics
- Operationalizing systems-based metabolic principles into durable fasting-informed weight plans
16:55 - 17:00
Q&A SESSION ON METABOLIC FEEDBACK LOOPS IN WEIGHT LOSS
17:00 - 18:00
NETWORKING DRINKS RECEPTION
Day 2 :
THURSDAY, APRIL 30, 2026
09:00 - 09:30
MORNING REFRESHMENTS
09:30 - 09:40
OPENING ADDRESS
09:40 - 10:05
ENSURING ACCESS AND SUPPORT IN OBESITY CARE
- Expanding patient access to obesity treatments through optimal payer coverage strategies
- Coordinating care models for GLP-1 therapy to provide comprehensive support for improved outcomes
- Forecasting future trends in obesity treatment by analyzing drug pipelines and the role of PBMs in care
10:05 - 10:10
Q&A SESSION ON ACCESS AND SUPPORT IN OBESITY TREATMENT
10:10 - 10:35
NA-931: AN ORAL QUADRUPLE RECEPTOR AGONIST FOR WEIGHT LOSS WITHOUT MUSCLE LOSS
10:35 - 10:40
Q&A SESSION ON NA-931 AND ADVANCES IN WEIGHT MANAGEMENT
10:40 - 11:05
TRANSFORMING OBESITY RESEARCH WITH METABOLIC TRACER TECHNOLOGIES
- Tracking patient fat synthesis, oxidation, and energy use directly with metabolic tracer assays
- Using tracer-based case studies that add valuable endpoints in metabolic disease trials
- Implementing tracer protocols into preclinical and clinical workflows without disrupting operations
- Aligning tracer platforms with GLP standards and regulators to speed adoption in obesity research
11:05 - 11:10
Q&A SESSION ON METABOLIC TRACERS IN OBESITY RESEARCH
11:10 - 11:30
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:30 - 11:55
METABOLIC ARCHITECTURE: THE PHYSIOLOGY OF A HIGH-RETENTION CLINICAL ECOSYSTEM
- Harmonizing pharmacotherapy, surgery, and lifestyle in a metabolic loop that preserves lean mass
- Standardizing care with the ABCDE framework so teams deliver consistent metabolic plans at scale
- Achieving a solvent, high-reliability clinic model with >65% retention and employer-aligned growth
11:55 - 12:00
Q&A SESSION ON HIGH-RETENTION METABOLIC CARE MODELS
12:00 - 12:25
BRIDGING CLINICAL EFFICACY AND SCALABLE ENTERPRISE IMPLEMENTATION: eMed's GLP-1 PROGRAM
- Specifying a digitally integrated, employer-based GLP-1 program with structured telehealth oversight
- Orchestrating prescribing, titration, safety checks, and at-home biomarker testing in obesity care
- Visualizing de-identified BMI, biomarker, and engagement trends for employers on secure dashboards
12:25 - 12:30
Q&A SESSION ON SCALABLE GLP-1 CARE DELIVERY MODELS
12:30 - 12:55
FINDING THE RARE IN THE MASS: USING RWE TO IDENTIFY RARE METABOLIC PHENOTYPES IN THE GLP-1 ERA
- Detecting GLP-1 non- and super-responders in RWE to uncover hidden rare metabolic phenotypes
- Profiling claims and EHR histories to flag GLP-1 non-responders suitable for disease screening
- Validating GLP-1 use in select rare conditions with RWE to support orphan indications and pricing
- Constructing synthetic control arms from historical data to speed trials in rare indications
12:55 - 13:00
Q&A SESSION ON RWE FOR RARE METABOLIC PHENOTYPES
13:00 - 13:25
AI-DRIVEN LIFESTYLE INTERVENTION IN THE NHS POPULATION
13:25 - 13:30
Q&A SESSION ON AI-DRIVEN NHS LIFESTYLE INTERVENTIONS
13:30 - 13:45
FEEDBACK AND RAFFLE DRAW
13:45 - 15:00
NETWORKING LUNCH
Become a Speaker & Join the Conversation
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.


































